000135899 001__ 135899
000135899 005__ 20180317092851.0
000135899 013__ $$aUS2010055066$$bUS$$cA1$$d20100304
000135899 013__ $$aEP1810689$$bEP$$cA4$$d20090722
000135899 013__ $$aEP1810689$$bEP$$cA1$$d20070725
000135899 013__ $$aWO2006041150$$bWO$$cA1$$d20060420
000135899 02470 $$2EPO Family ID$$a36148436
000135899 02470 $$2EPO Family ID$$a38890137
000135899 037__ $$aPATENT
000135899 245__ $$aPreventive and/or therapeutic agents for diabetes
000135899 260__ $$c2006
000135899 269__ $$a2006
000135899 336__ $$aPatents
000135899 500__ $$aApplicant(s): Mitsubishi Pharma Corp [Jp]
000135899 520__ $$aA preventive and/or therapeutic agent for diabetes, comprising a substance capable of inhibiting the activity of farnesoid X receptor as an active ingredient
000135899 700__ $$aSuzuki, K.
000135899 700__ $$aSakai, K.
000135899 700__ $$aIshii, S.
000135899 700__ $$aSugimoto, K.
000135899 700__ $$0240040$$aAuwerx, J.$$g185233
000135899 700__ $$aWatanabe, M.
000135899 909CO $$ooai:infoscience.tind.io:135899$$pSV
000135899 909C0 $$0252023$$pNCEM$$xU11905
000135899 937__ $$aNCEM-PATENT-2006-001
000135899 973__ $$aOTHER$$sPUBLISHED
000135899 980__ $$aPATENT